This archive contains the following articles listed by volume, issue and page number:
 |
|
|
QUALITY CONTROL RELATED ARTICLES |
Title (Click for Details) |
Vol/Issue |
Page |
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators |
Vol. 23 No. 6 |
447 |
How to Qualify Container Closure Systems for Intended Use, Part 1 |
Vol. 23 No. 6 |
454 |
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 |
Vol. 23 No. 6 |
467 |
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives |
Vol. 23 No. 6 |
472 |
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 |
Vol. 23 No. 5 |
387 |
Contamination Control in Compounding Areas |
Vol. 23 No. 4 |
271 |
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations |
Vol. 23 No. 4 |
281 |
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing |
Vol. 23 No. 4 |
299 |
Summary of Educational Offerings Provided by Compounding Support Companies in 2019 |
Vol. 23 No. 3 |
188 |
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing |
Vol. 23 No. 3 |
211 |
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding |
Vol. 23 No. 3 |
221 |
An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability |
Vol. 23 No. 3 |
258 |
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? |
Vol. 23 No. 2 |
123 |
Towards the Importance of a Roller Mill in Compounding Practice: An Experimental Approach |
Vol. 23 No. 2 |
154 |
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line |
Vol. 23 No. 1 |
32 |
Basics of Compounding: Standardization of Compounded Medications |
Vol. 23 No. 1 |
35 |
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding |
Vol. 23 No. 1 |
47 |
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
|
Vol. 22 No. 6 |
475 |
PreScription: Updating Formulations |
Vol. 22 No. 5 |
356 |
Current Trends and Emerging Priorities in Compounded Preparations for Children |
Vol. 22 No. 5 |
358 |
Certification of Powder-containment Hoods for Nonsterile Compounding |
Vol. 22 No. 5 |
369 |
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations |
Vol. 22 No. 5 |
387 |
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 |
Vol. 22 No. 5 |
401 |
Quality Control: Water Activity Considerations for Beyond-use Dates |
Vol. 22 No. 4 |
288 |
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 |
Vol. 22 No. 4 |
294 |
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating |
Vol. 22 No. 4 |
303 |
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags |
Vol. 22 No. 4 |
345 |
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding |
Vol. 22 No. 3 |
206 |
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy |
Vol. 22 No. 2 |
129 |
Basics of Compounding: Compounding Microemulsions |
Vol. 22 No. 2 |
137 |
PreScription: 2017--Some Good Things Happened and Some Others |
Vol. 22 No. 1 |
4 |
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies |
Vol. 22 No. 1 |
7 |
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy |
Vol. 22 No. 1 |
41 |
Orodispersible Films for Compounding Pharmacies |
Vol. 21 No. 6 |
454 |
Features of Pharmaceutical Compounding in the Republic of Tajikistan |
Vol. 21 No. 6 |
463 |
Basics of Compounding: Hot Melt Extrusion |
Vol. 21 No. 6 |
471 |
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations |
Vol. 21 No. 6 |
481 |
Validation of the Technological Process of the Preparation "Milk by Vidal" |
Vol. 21 No. 6 |
513 |
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland |
Vol. 21 No. 6 |
518 |
Documentation: Records and Reports |
Vol. 21 No. 5 |
373 |
Basics of Sterile Compounding: Particulate Matter |
Vol. 21 No. 5 |
395 |
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) |
Vol. 21 No. 5 |
418 |
Component Selection for Sterile Compounding |
Vol. 21 No. 4 |
277 |
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future |
Vol. 21 No. 4 |
293 |
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Vol. 21 No. 3 |
180 |
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding |
Vol. 21 No. 3 |
182 |
Microbiologic Testing for 503A Sterile-Compounding Pharmacies |
Vol. 21 No. 3 |
193 |
Basics of Sterile Compounding: Manipulating Peptides and Proteins |
Vol. 21 No. 3 |
223 |
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies |
Vol. 21 No. 2 |
95 |
Quality Control: (Material) Safety Data Sheets |
Vol. 21 No. 2 |
118 |
Accuracy Considerations in Sterile Compounding |
Vol. 21 No. 2 |
133 |
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules |
Vol. 21 No. 2 |
171 |
Analytic Methods Used in Quality Control in a Compounding Pharmacy |
Vol. 21 No. 1 |
31 |
Basics of Compounding with Dilutions and Concentrates |
Vol. 21 No. 1 |
39 |
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) |
Vol. 20 No. 6 |
457 |
Why Become Pharmacy Compounding Accreditation Board Accredited? |
Vol. 20 No. 6 |
469 |
The "Lists": What Do They Mean? |
Vol. 20 No. 6 |
477 |
Introduction to Quality Control in a Compounding Pharmacy |
Vol. 20 No. 6 |
481 |
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments |
Vol. 20 No. 6 |
495 |
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals |
Vol. 20 No. 5 |
356 |
Quality Control Analytical Methods: Method Validation |
Vol. 20 No. 5 |
381 |
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 |
Vol. 20 No. 4 |
283 |
Basics of Compounding: Compounding Films |
Vol. 20 No. 4 |
298 |
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding |
Vol. 20 No. 4 |
307 |
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines |
Vol. 20 No. 4 |
351 |
PreScription: Patient Access to Pharmaceuticals |
Vol. 20 No. 3 |
180 |
Topical Metered-dosing Dispenser Performance Evaluation |
Vol. 20 No. 3 |
239 |
Root Cause Analysis, Part 2: Sterile Compounding |
Vol. 20 No. 2 |
99 |
Basics of Compounding: Capsules |
Vol. 20 No. 2 |
125 |
Formulation and Stability of Solutions |
Vol. 20 No. 2 |
137 |
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) |
Vol. 20 No. 2 |
148 |
Microbial Identification in Pharmaceutical Compounding |
Vol. 20 No. 1 |
13 |
Basic Principles of Lyophilization, Part 2 |
Vol. 20 No. 1 |
20 |
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success |
Vol. 20 No. 1 |
29 |
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation |
Vol. 20 No. 1 |
63 |
PostScription: The Home Field Advantage |
Vol. 20 No. 1 |
86 |
Applying Quality of Design Concepts to Pharmacy Compounding |
Vol. 19 No. 6 |
453 |
Root Cause Analysis, Part 1: Nonsterile Compounding |
Vol. 19 No. 6 |
465 |
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations |
Vol. 19 No. 5 |
383 |
Sterile Filtration |
Vol. 19 No. 5 |
393 |
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom |
Vol. 19 No. 4 |
268 |
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 |
Vol. 19 No. 4 |
280 |
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units |
Vol. 19 No. 4 |
307 |
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals |
Vol. 19 No. 4 |
340 |
IACP Says: "Fix DQSA" |
Vol. 19 No. 3 |
212 |
Quality Assurance and Quality Control, Part 2 |
Vol. 19 No. 3 |
215 |
Standarized Compounding: The Importance of Doing it the Same Way Every Time |
Vol. 19 No. 2 |
109 |
Quality Assurance and Quality Control, Part 1 |
Vol. 19 No. 2 |
121 |
PreScription: 2014 in Review |
Vol. 19 No. 1 |
4 |
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance |
Vol. 19 No. 1 |
30 |
Quality Control Analytical Methods: Refractive Index |
Vol. 19 No. 1 |
43 |
Basics of Sterile Compounding: Aseptic Processing |
Vol. 19 No. 1 |
49 |
Depyrogenation Options for the Compounding Cleanroom |
Vol. 18 No. 6 |
446 |
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date |
Vol. 18 No. 6 |
456 |
Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry? |
Vol. 18 No. 6 |
475 |
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous |
Vol. 18 No. 6 |
486 |
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products |
Vol. 18 No. 6 |
520 |
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future |
Vol. 18 No. 6 |
526 |
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy |
Vol. 18 No. 5 |
358 |
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know |
Vol. 18 No. 5 |
397 |
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment |
Vol. 18 No. 5 |
401 |
PostScription: The Future of Veterinary Compounding |
Vol. 18 No. 5 |
438 |
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety |
Vol. 18 No. 4 |
270 |
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 |
Vol. 18 No. 4 |
305 |
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding |
Vol. 18 No. 4 |
341 |
PostScription: Responsibilities of a Compounding Pharmacist |
Vol. 18 No. 4 |
351 |
PreScription: Déjà Vu All Over Again |
Vol. 18 No. 3 |
180 |
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter |
Vol. 18 No. 3 |
208 |
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 |
Vol. 18 No. 3 |
213 |
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety |
Vol. 18 No. 3 |
222 |
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms |
Vol. 18 No. 3 |
242 |
Investigation of Physical and Chemical Stability of an Ointment with Herbals |
Vol. 18 No. 3 |
248 |
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards |
Vol. 18 No. 2 |
94 |
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective |
Vol. 18 No. 2 |
101 |
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities |
Vol. 18 No. 2 |
117 |
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding |
Vol. 18 No. 2 |
123 |
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume |
Vol. 18 No. 2 |
131 |
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions |
Vol. 18 No. 2 |
137 |
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy |
Vol. 18 No. 2 |
159 |
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding |
Vol. 18 No. 2 |
162 |
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 |
Vol. 18 No. 1 |
6 |
Good Enough for America |
Vol. 18 No. 1 |
20 |
Determination of Risk for Sterile Preparations |
Vol. 18 No. 1 |
30 |
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks |
Vol. 18 No. 1 |
42 |
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding |
Vol. 18 No. 1 |
46 |
Basics of Sterile Compounding: Bubble Point Testing |
Vol. 18 No. 1 |
54 |
E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project |
Vol. 18 No. 1 |
83 |
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies |
Vol. 17 No. 6 |
465 |
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? |
Vol. 17 No. 6 |
480 |
Calculations |
Vol. 17 No. 6 |
496 |
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds |
Vol. 17 No. 6 |
512 |
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions |
Vol. 17 No. 5 |
356 |
Compounding Pharmacies: Before and After an Inspection |
Vol. 17 No. 5 |
358 |
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms |
Vol. 17 No. 5 |
364 |
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach |
Vol. 17 No. 5 |
393 |
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs |
Vol. 17 No. 5 |
424 |
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters |
Vol. 17 No. 5 |
439 |
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations |
Vol. 17 No. 4 |
307 |
Basics of Compounding: Foam Dosage Forms |
Vol. 17 No. 4 |
312 |
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs |
Vol. 17 No. 4 |
347 |
PostScription: Traditional vs Nontraditional Pharmacy |
Vol. 17 No. 4 |
351 |
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists |
Vol. 17 No. 3 |
182 |
Decontamination Technology: The Missing Element |
Vol. 17 No. 3 |
193 |
International Academy of Compounding Pharmacists' Legislative/Regulatory Update |
Vol. 17 No. 3 |
206 |
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations |
Vol. 17 No. 3 |
210 |
Basics of Compounding: Potency and Stability Testing |
Vol. 17 No. 3 |
220 |
Sterilization of Compounded Parenteral Products: Verification of Autoclaves |
Vol. 17 No. 2 |
94 |
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program |
Vol. 17 No. 2 |
130 |
Basics of Compounding: Repackaging, Part 2 |
Vol. 17 No. 2 |
136 |
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings |
Vol. 17 No. 2 |
168 |
Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves |
Vol. 17 No. 1 |
50 |
Basics of Compounding: Repackaging, Part 1 |
Vol. 17 No. 1 |
54 |
PostScription: GMPs and GCPs: A Topical Comparison |
Vol. 17 No. 1 |
87 |
Quality Control: Analytical Methods. Certificates of Analysis, Part 1 |
Vol. 16 No. 6 |
486 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel |
Vol. 16 No. 6 |
490 |
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 2 |
Vol. 16 No. 5 |
396 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging |
Vol. 16 No. 5 |
405 |
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 1 |
Vol. 16 No. 4 |
312 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing |
Vol. 16 No. 4 |
322 |
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets |
Vol. 16 No. 4 |
342 |
Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis? |
Vol. 16 No. 3 |
226 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification |
Vol. 16 No. 3 |
230 |
Calculations |
Vol. 16 No. 3 |
236 |
Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy |
Vol. 16 No. 3 |
253 |
PostScription: Rules for Pharmaceutically Elegant Calculations |
Vol. 16 No. 3 |
262 |
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes |
Vol. 16 No. 2 |
98 |
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 2 |
Vol. 16 No. 2 |
104 |
Quality Control: 5 Steps to Improve Quality in the Compounding Lab |
Vol. 16 No. 2 |
136 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 |
Vol. 16 No. 2 |
146 |
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone |
Vol. 16 No. 1 |
86 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4 |
Vol. 16 No. 1 |
64 |
Calculations |
Vol. 16 No. 1 |
69 |
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire |
Vol. 15 No. 6 |
474 |
Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need |
Vol. 15 No. 6 |
480 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3 |
Vol. 15 No. 6 |
488 |
Calculations |
Vol. 15 No. 6 |
498 |
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant |
Vol. 15 No. 6 |
521 |
PreScription: American Pharmacists Month: A Time for Taking Responsibility |
Vol. 15 No. 5 |
356 |
Lessons Learned from a Continuous Quality-Improvement Testing Program |
Vol. 15 No. 5 |
372 |
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons |
Vol. 15 No. 5 |
390 |
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions |
Vol. 15 No. 5 |
428 |
PostScription: Compounders Go Above and Beyond in the Name of Safety |
Vol. 15 No. 5 |
438 |
Quality-Control Analytical Methods: Using Purified Water for Reconstitutions |
Vol. 15 No. 4 |
322 |
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy |
Vol. 15 No. 4 |
278 |
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions |
Vol. 15 No. 3 |
224 |
Basics of Compounding: Basics of Compounding with Complex Organic Molecules |
Vol. 15 No. 3 |
234 |
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 |
Vol. 15 No. 2 |
133 |
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management |
Vol. 15 No. 1 |
20 |
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations |
Vol. 15 No. 1 |
49 |
PostScription: Profile of a Pharmacy Compounding Accreditation Board–Accredited Pharmacy: Vital Care of Meridian |
Vol. 15 No. 1 |
86 |
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 |
Vol. 14 No. 6 |
493 |
Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates |
Vol. 14 No. 6 |
508 |
PreScription: Compounding with Manufactured Products |
Vol. 14 No. 6 |
448 |
In the Hands of Your Enemy |
Vol. 14 No. 6 |
456 |
Barrier Isolator/Glovebox Glove Dexterity Study |
Vol. 14 No. 6 |
526 |
PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy |
Vol. 14 No. 6 |
531 |
Home Infusion Accreditation: Another Quality Recognition Branding Tool |
Vol. 14 No. 5 |
360 |
Basics of Compounding: Basics of Compounding with Esters |
Vol. 14 No. 5 |
416 |
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study |
Vol. 14 No. 5 |
430 |
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 |
Vol. 14 No. 5 |
407 |
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board |
Vol. 14 No. 5 |
440 |
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device |
Vol. 14 No. 5 |
436 |
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents |
Vol. 14 No. 4 |
284 |
Thyroid Potency Calculations |
Vol. 14 No. 4 |
306 |
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters |
Vol. 14 No. 4 |
317 |
Basics of Compounding: Basics of Compounding with Organic Salts |
Vol. 14 No. 4 |
322 |
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program |
Vol. 14 No. 4 |
328 |
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping |
Vol. 14 No. 4 |
342 |
PreScription: Quality Improvement in Pharmaceutical Compounding |
Vol. 14 No. 3 |
180 |
Quality Control Analytical Methods: Continuous Quality Improvement |
Vol. 14 No. 3 |
218 |
Basics of Compounding: Compounding with Hydrates and Solvates |
Vol. 14 No. 3 |
222 |
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations |
Vol. 14 No. 3 |
232 |
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration |
Vol. 14 No. 3 |
250 |
Weight Uniformity of Scored Tablet Halves Manufactured by Palestinian Pharmaceutical Companies |
Vol. 14 No. 3 |
257 |
Quality Control: From Record Keeping to Key Performance Indicators: Managing Quality in Compounding Pharmacies |
Vol. 14 No. 2 |
136 |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests |
Vol. 14 No. 2 |
142 |
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector |
Vol. 14 No. 2 |
160 |
Prophylaxis Against Exposure to Bloodborne Pathogens During Compounding |
Vol. 14 No. 1 |
14 |
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting |
Vol. 14 No. 1 |
32 |
Literature Review & Importance of Quality Control |
Vol. 14 No. 1 |
54 |
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control |
Vol. 14 No. 1 |
60 |
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust |
Vol. 13 No. 6 |
532 |
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops |
Vol. 13 No. 6 |
540 |
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy |
Vol. 13 No. 5 |
412 |
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care? |
Vol. 13 No. 4 |
318 |
Quality-Control Analytical Methods: Pharmaceutical and Analytical Considerations of the Significance of pH |
Vol. 13 No. 3 |
230 |
Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations |
Vol. 13 No. 2 |
128 |
Quality-Control Analytical Methods: Compounding Slow-Release Pharmaceuticals |
Vol. 13 No. 2 |
144 |
Identifying the Criteria of a Valid Stability Study |
Vol. 13 No. 1 |
32 |
Quality Control Analytical Methods: Testing of Electrolytes Solutions |
Vol. 13 No. 1 |
53 |
Testing of Estradiol in a Compounded Cream and a Stock Solution |
Vol. 13 No. 1 |
74 |
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials |
Vol. 13 No. 1 |
81 |
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations |
Vol. 12 No. 6 |
524 |
Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting |
Vol. 12 No. 4 |
316 |
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists |
Vol. 12 No. 4 |
321 |
Quality-Control Analytical Methods: Homogeneity of Dosing Forms |
Vol. 12 No. 4 |
340 |
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards |
Vol. 12 No. 3 |
216 |
A Process Verification Model for Quality Assurance in a Compounding Pharmacy |
Vol. 12 No. 3 |
247 |
Establishing a Quality-Assurance Program for Hospital Compounding |
Vol. 12 No. 2 |
116 |
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! |
Vol. 12 No. 2 |
130 |
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method |
Vol. 12 No. 1 |
50 |
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds |
Vol. 11 No. 6 |
487 |
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests |
Vol. 11 No. 5 |
400 |
Quality-control Analytical Methods: Logbooks and Documentation Forms |
Vol. 11 No. 4 |
306 |
Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations |
Vol. 11 No. 3 |
226 |
Records and Record-Keeping for the Hospital Compounding Pharmacist |
Vol. 11 No. 2 |
138 |
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms |
Vol. 11 No. 2 |
145 |
Quality Control Analytical Methods: The Quality of Sterility Testing |
Vol. 11 No. 1 |
52 |
PostScription: Challenges Facing an Analytical Laboratory |
Vol. 10 No. 6 |
479 |
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations |
Vol. 10 No. 6 |
469 |
Quality Control Analytical Methods: Continuous Quality Improvement |
Vol. 10 No. 6 |
442 |
Quality-Control Analytical Methods: Sterility Failure Investigations |
Vol. 10 No. 5 |
372 |
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations |
Vol. 10 No. 5 |
381 |
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist |
Vol. 10 No. 4 |
281 |
Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight |
Vol. 10 No. 4 |
291 |
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> |
Vol. 10 No. 4 |
309 |
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations |
Vol. 10 No. 4 |
253 |
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? |
Vol. 10 No. 3 |
202 |
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations |
Vol. 10 No. 1 |
36 |
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results |
Vol. 10 No. 1 |
41 |
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products |
Vol. 9 No. 6 |
462 |
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding |
Vol. 9 No. 4 |
300 |
Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions |
Vol. 9 No. 3 |
207 |
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations |
Vol. 9 No. 2 |
136 |
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing |
Vol. 9 No. 1 |
11 |
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations |
Vol. 9 No. 1 |
47 |
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? |
Vol. 9 No. 1 |
53 |
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations |
Vol. 8 No. 6 |
466 |
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations |
Vol. 8 No. 6 |
479 |
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating |
Vol. 8 No. 5 |
393 |
Quality-Control Analytical Methods: Gas Chromatography |
Vol. 8 No. 4 |
305 |
Quality-Control Analytical Methods: High-Performance Liquid Chromatography |
Vol. 8 No. 3 |
223 |
Quality-Control Analytical Methods: Osmolality and Osmometry |
Vol. 8 No. 2 |
143 |
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution |
Vol. 8 No. 2 |
147 |
Quality-Control Analytical Methods: Selecting an Analytical Method |
Vol. 8 No. 1 |
61 |
Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids |
Vol. 7 No. 6 |
477 |
Application of USP-NF Standards to Pharmacy Compounding |
Vol. 7 No. 5 |
361 |
Quality-Control Analytical Methods: Refractometry |
Vol. 7 No. 5 |
383 |
Quality-Control Analytical Methods: Viscosity Measurements |
Vol. 7 No. 4 |
305 |
Accuracy of Graduated Cylinders |
Vol. 7 No. 3 |
208 |
Product Containment in the Compounding Laboratory |
Vol. 7 No. 3 |
213 |
Quality-Control Analytical Methods: Principles of pH |
Vol. 7 No. 3 |
225 |
The Cost of Quality in Pharmacy |
Vol. 6 No. 6 |
404 |
Comparison of Endotoxin Testing Methods for Pharmaceutical Products |
Vol. 6 No. 6 |
408 |
Quality in Pharmacy: The New Zealand Experience |
Vol. 6 No. 5 |
354 |
PostScription-Ensuring Compounding Excellence: Quality Control or Quality Assurance? |
Vol. 6 No. 2 |
160 |
Quality Assurance for Sterile Products |
Vol. 5 No. 4 |
246 |
Analytical Testing Facilities and Products |
Vol. 5 No. 4 |
284 |
Analytical Testing of Extemporaneously Compounded Preparations |
Vol. 4 No. 2 |
105 |
Analysis of Extemporaneous Alprostadil Formulations |
Vol. 3 No. 2 |
148 |
Testing for Bacterial Endotoxins |
Vol. 2 No. 5 |
379 |
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations |
Vol. 2 No. 3 |
192 |
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms |
Vol. 1 No. 5 |
349 |